Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 2/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.62 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.62 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.62 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.60 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.53 |
| ▸ | CASP1 | P29466 | 1/20 | 0.53 |
| ▸ | CASP7 | P55210 | 1/20 | 0.53 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.52 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.49 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.49 |
| ▸ | NR2F2 | P24468 | 1/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16029602 | 0.93 | ALDH1A1 (0.67) | POLBALDH1A1CYP2C19CYP1A2CYP3A4 | |
| SCHEMBL3860921 | 0.87 | ALDH1A1 (0.65) | POLBALDH1A1CYP2C19CYP1A2CYP3A4 | |
| SCHEMBL3389758 | 0.83 | ALDH1A1 (0.82) | POLBALDH1A1CYP2C19CYP1A2CYP3A4 | |
| SCHEMBL22522002 | 0.80 | HTT (0.54) | POLBALDH1A1CYP2C19CYP1A2CYP3A4 | |
| SCHEMBL516379 | 0.80 | POLB (1.00) | POLBALDH1A1CYP2C19CYP1A2CYP3A4 | |
| SCHEMBL16029861 | 0.79 | POLB (0.56) | POLBALDH1A1CYP2C19CYP1A2CYP3A4 | |
| SCHEMBL3455612 | 0.78 | POLB (0.75) | POLBALDH1A1CYP2C19CYP1A2CYP3A4 | |
| SCHEMBL16029596 | 0.78 | POLB (0.49) | POLBALDH1A1CYP2C19CYP1A2CYP3A4 | |
| SCHEMBL5717642 | 0.78 | ALDH1A1 (0.74) | POLBALDH1A1CYP2C19CYP1A2CYP3A4 | |
| SCHEMBL925084 | 0.78 | ALDH1A1 (0.92) | POLBALDH1A1CYP2C19CYP1A2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2970316-B1 | SUBSTITUTED XANTHINES AND METHODS OF USE THEREOF | HYDRA BIOSCIENCES INC (US) | 2017-11-08 | — | — | EP | disclosed |
| EP-2970316-B1 | SUBSTITUTED XANTHINES AND METHODS OF USE THEREOF | HYDRA BIOSCIENCES INC (US) | 2017-11-08 | — | — | EP | disclosed |
| US-20160145257-A1 | SUBSTITUTED XANTHINES AND METHODS OF USE THEREOF | HYDRA BIOSCIENCES, INC. | 2016-05-26 | — | — | US | disclosed |
| US-20160145257-A1 | SUBSTITUTED XANTHINES AND METHODS OF USE THEREOF | HYDRA BIOSCIENCES, INC. | 2016-05-26 | — | — | US | disclosed |
| WO-2014152287-A9 | SUBSTITUTED XANTHINES AND METHODS OF USE THEREOF | HYDRA BIOSCIENCES, INC. (US) | 2015-04-23 | — | — | WO | disclosed |
| WO-2014152287-A2 | SUBSTITUTED XANTHINES AND METHODS OF USE THEREOF | HYDRA BIOSCIENCES, INC. (US) | 2014-09-25 | — | — | WO | disclosed |
| US-20140275528-A1 | SUBSTITUTED XANTHINES AND METHODS OF USE THEREOF | HYDRA BIOSCIENCES, INC. (US) | 2014-09-18 | — | — | US | disclosed |
| US-20140275528-A1 | SUBSTITUTED XANTHINES AND METHODS OF USE THEREOF | HYDRA BIOSCIENCES, INC. (US) | 2014-09-18 | — | — | US | disclosed |
| US-20120027897-A1 | Methods For Quantifying The Complete Nutritional Value Of A Standard Equivalent Unit Of The Nutritional Value Of One Serving Of Fruits & Vegetables (SFV)And For Fortifying A Base Food To Contain Same For Human Consumption | INNOCENZI MARK A (US) | 2012-02-02 | — | — | US | disclosed |
| US-8053007-B2 | Compositions and methods for fortifying a base food to contain the complete nutritional value of a standard equivalent unit of the nutritional value of one serving of fruits and vegetables (“SFV”) for human consumption | Innocenzi, Mark (US) | 2011-11-08 | — | — | US | disclosed |
| US-20110250318-A1 | COMPOSITIONS AND METHODS FOR FORTIFYING A BASE FOOD TO CONTAIN THE COMPLETE NUTRITIONAL VALUE OF ONE SERVING OF FRUITS AND VEGTABLES (\"SFV\") FOR HUMAN CONSUMPTION | INNOCENZI MARK | 2011-10-13 | — | — | US | disclosed |
| US-6703056-B2 | .01-10% OF ARABINOGALACTAN, AND ZINC, IRON, MAGNESIUM, CALCIUM, SELENIUM, IODINE, OR FLUORINE | THE PROCTER + GAMBLE CO. | 2004-03-09 | — | — | US | disclosed |
| US-20020136802-A1 | Beverage compositions comprising arabinogalactan and defined minerals | THE PROCTER & GAMBLE CO. | 2002-09-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160145257-A1 | SUBSTITUTED XANTHINES AND METHODS OF USE THEREOF | TRPC5, TRPC7, TRPC4 | POLB 3162/4885ALDH1A1 1647/4885CYP2C19 3004/4885 |
| US-20140275528-A1 | SUBSTITUTED XANTHINES AND METHODS OF USE THEREOF | TRPC5, TRPC7, TRPC4 | POLB 3162/4885ALDH1A1 1647/4885CYP2C19 3004/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.